Updated: Dec. 19, 2011 (Initial publication: July 5, 2011)

Sectorial Analysis

II-9.5: A recommendation concerning “good practices” published by the French healthcare regulator was invalidated for reasons of partiality

by Camille Feuillat

Translated Summaries


ENGLISH

A recommendation concerning professional “good practices” in pharmaceutical treatments issued by the Haute Autorité de la Santé (French Healthcare Regulator) was attacked before the Council of State by an association. It was invalidated by Council of State decision on April 27, 2011 for violation of the principal of impartiality, because members of the regulator’s working group had interests in the pharmaceutical industry.


ITALIAN

Relazione di settore (Salute): Una raccomandazione sulle “buone prassi” pubblicata dall’Autorità di regolazione in material di salute è stata annullata a ragione della sua parzialità

Una raccomandazione relativa alle “buone prassi” nei trattamenti farmaceutici resa dalla Haute Autorité de la Santé (l’autorità francese di regolazione in materia di salute) era stata contestata da un’associazione dinanzi al Consiglio di Stato. Il 27 aprile 2011, il Consiglio di Stato ha annullato tale raccomandazione in quanto resa in violazione del principio d’imparzialità, diversi membri del gruppo di lavoro nominati dall’autorità di regolazione avevano interessi personali nell’industria farmaceutica.


 SPANISH

Informe Temático (Salud): Una recomendación concerniendo las “buenas prácticas” publicada en por el regulador francés de la salud fue invalidada por razones de parcialidad.

 Una recomendación concerniendo las “buenas prácticas” en tratamientos farmacéuticos publicada por la Haute Autorité de la Santé (el Regulador francés de la salud) fue atacada frente al Consejo de Estado por una asociación. Fue invalidada por el Consejo de Estado en una decisión del 27 de abril del 2011 por violación del principio de la imparcialidad, porque miembros del grupo de trabajo del regulador tenían ciertos intereses en la industria farmacéutica.

 

PORTUGUESE

Informe setorial (Saúde): Uma recomendação relativa a “boas práticas” publicada pelo regulador francês de saúde foi anulada por motivos de parcialidade.


Uma recomendação relativa a “boas práticas” em tratamentos farmacêuticos adotada pela Haute Autorité de la Santé (Regulador francês de saúde) foi atacada perante o Conselho de Estado por uma associação. Ela foi invalidada pela decisão do Conselho de Estado de 27 de abril de 2011 por violação do princípio da imparcialidade, pois alguns membros do grupo de trabalho do regulador tinham interesses na indústria farmacêutica.


Revogação – Ônus da prova – Conflito de interesses – Deontologia – Ex post – Boas práticas – Guia – Hard Law – Haute Autorité de la Santé (Regulador Francês da Saúde) – Imparcialidade – Independência – Legislador – Responsabilidade – Programa de tratamento médico – Obrigação – Parcialidade – Indústria farmacêutica – Recomendação – Ciência – Autoridade científica – Dados científicos – Grupo de trabalho.*


* Em The Journal of Regulation, estas palavras-chave são fornecidas pelo Editor e não pelo Autor.

 

.....................

Other translations forthcoming.

Themes

Context and Summary

On April 27, 2011, the first and sixth chambers of the French Council of State’s litigation section rendered its decision in the Association pour une formation médicale indépendante Case, concerning a recommendation published by the Haute Autorité de la Santé concerning diabetes treatment programs. The decision states that the Haute Autorité de la Santé is a “public, independent, scientific authority with legal personality.” Article L161-37 of the Social Security Code gives it the power to create guides concerning the correct use of therapies and make recommendations concerning good practices.

The decision at hand refers to Article R.161-72 of the same code to point out that these recommendations are supposed to guide healthcare professionals in their implementation of treatment programs. The decision states that because medical professionals have a deontological imperative to implement therapies based on scientific data, especially as set forth by these recommendations concerning good practices, these recommendations “must be regarded as grievous decisions that are admissible for an ultra vires plea.” According to the Council of State, the Authority’s refusal to abrogate its recommendation is also grievous.

The Act’s legality is also attacked with regards to the principle of impartiality. Article L-161-44 of the Social Security Code demands that the members of the Authority and all persons aiding it in its missions “have no interest susceptible of compromising their independence” in companies that have a direct interest in the subjects at hand. The association appealing the decision brought “proof of elements susceptible of establishing conflict of interest concerning certain persons having participated in the working group with companies or establishments dealing with the treatment of diabetes.”

During the proceedings, the judge requested that the Authority provide the declarations of conflict of interest furnished by all members of the group, but only obtained 23 such documents, even though there were 27 members of the group. The judge therefore ruled that he did not have the means to ensure the absence of such conflicts of interest for those members, whose declarations were obligatory, and to judge whether these documents might reveal conflicts of interest.

The Council of State concluded that the recommendation was irregularly drawn up, and ruled in favor of the association’s appeal.

The recommendation was abrogated by the judge.

..........

To read the decision in French, please, click here.

Brief commentary

This decision is very interesting in its three successive points, and its logic can be extended to other industries.
The first point allows us to better apprehend the power of soft law. The second point demonstrates judges’ artfulness in escaping the strategies of inertia often employed by powerful litigants in cases having to do with regulated industries. The third point concerns conflicts of interest.
The recommendation at hand is a professional recommendation concerning medicines for the treatment of diabetes. It is therefore part of soft law, and the judge could have refused to hear the appeal, since it has no mandatory force for healthcare professionals. The mandatory nature of the text should determine whether we are faced with soft law or hard law: following this binary logic, it would be difficult indeed to consider that the recommendation was “grievous.”
But the Council of State used two notions to arrive at the opposite conclusion: it considered that the recommendation defines “data acquired by science,” meaning it guides healthcare professionals, impacts their liability ex post, and professionals have at the very least a deontological obligation to base their treatment strategies on the scientific data contained in these recommendations.
This double reference, both objective (scientific data recapitulated in the recommendation) and subjective (professionals’ deontological obligation to follow the recommendation) make the recommendation grievous.
One can only applaud the finesse demonstrated by the judge. First of all, the distinction between soft and hard law is overly simplistic: there exists a continuum between the two in regulate sectors where science and expertise hold a central role and gently slide into a sort of soft law that has effects on behavior that are often more imperious than an order produced by lawmakers. Secondly, it would be too easy to ceaselessly emit soft law, a standard followed by professionals, while escaping judicial control with the allegation that the recommendation was not formally mandatory. It might be thought more generally that judicial review of regulators will be increased by this decision and that this type of logic will be extended to other industries.
The second point is the way the judge succeeded in overcoming the Authority’s inertia. The administrative judge has always been better able than the regular judge to overcome the power of the government. The primary manifestation of this power is inertia faced with citizens. Here, we see the classic solution in administrative law, that even though the burden of proof lies on the defendant, when he does not feed the debate with proof, he allows the appellant to triumph.
In regulatory law, which is very concerned with administrative law techniques, this is an “art of war” that regulators, powerful government officials, must keep in mind.
The third point is the most simple because it concerns conflicts of interest. Conflicts of interest have become an obsession. They are the Gordian knot that rules, professional engagements, and behaviors try to untie in banking and finance. But, with this decision, the healthcare industry has demonstrated something that is applicable to all industries: in very complex subjects where scientific data is rapidly obsolete, operators have to frequent one another in order to remain competent. Too many decisions such as the one at hand will mean that nobody will want to participate in working groups, whose members are usually not remunerated, except for incompetents and pensioners.

your comment